Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 218-229

  Kaneko, H ^a,b   Saito, K ^a,b   Hashimoto, H ^a   Yagita, H ^a   Okumura, K ^a   Azuma, M ^a,c  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

apoptosis; CD28; systemic lupus erythematosus; T cell activation

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPENIA; MALE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0029841476     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-849.x     Document Type: Article

References (66)

1. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 48:1349 56.
2. Harding FA, McArthur JG, Gross JA et al. CD28 mediated signaling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 1992; 356:607-9.
3. Russell JH, White CL, Loh DY et al. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 1991; 88:2151 5.
4. Radvanyi LG, Mills GB, Miller RG. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 1993; 150: 5704-15.
5. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150:4338 45.
6. Mueller DL, Jenkins MK, Schwartz RH. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J Immunol 1989; 142:2617 28.
7. Freeman GJ, Freedman AS, Segil JM et al. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989; 143:2714 22.
8. Freedman AS, Freeman G, Horowitz JC et al. B7, a B cell-restricted antigen that identities preactivated B cells. J Immunol 1987; 139: 3260 7.
9. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366:76-79.
10. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2; a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262:909-11.
11. Azuma M, Cayabyab M, Buck D et al. CD28 interaction with B7 co-stimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992; 175:353-60.
12. Lanier LL, O'Fallon S, Somoza C et al. CDSO (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of cytotoxic T lymphocytes. J Immunol 1995; 154:97 105.
13. Hansen JA, Martin PJ, Nowinski RC. Monoclonal antibodies identifying a novel T-cell antigen and la antigens of human lymphocytes. Immunogenetics 1980; 10:247 60.
14. Yamada H, Martin PJ, Braun MP et al. Monoclonal antibody 9·3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes. Eur J Immunol 1985; 15:1164 8.
15. Azuma M, Phillips JH, Lanier LL. CD28 T lymphocytes: antigenic and functional properties. J Immunol 1993; 150:1147 59.
16. + cells with a limited alloreactive T cell receptor repertoire. J Immunol 1989; 143:2783 9.
17. + T cells. J Immunol 1993; 151:2237 46.
18. Pollice AA, McCoy JPJ, Shackney SE et al. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 1992; 13:432 44.
19. + lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 1991; 21:737 41.
20. + lymphocytes from bone marrow transplantated patients inhibits cell mediated cytolysis. Blood 1991; 77: 2237 41.
21. + suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J Immunol 1996; 137: 2180 9.
22. Maher PA, Singer SJ. Anomalous interaction of the acetylcholine receptor protein with the nonionic detergent Triton X-114. Proc Natl Acad Sci USA 1995; 82:958 62.
23. Nakata M, Kawasaki A, Azuma M et al. Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. Int Immunol 1992; 4:1049 54.
24. Osman C, Swaak AJG. Lymphocytotoxic antibodies in SLE: a review of the literature. Clin Rheumatol 1994; 13:21 27.
25. Alderson MR, Tough TW, Davis-Smith T et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1993; 181:71 77.
26. Ju ST, Panka DJ, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444-8.
27. Tan EM. Autoimmunity and apoptosis. J Exp Med 1994; 179:1083 6.
28. Tan EM, Cohen A, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
29. Cifone MG, de Maniai R, Roncaioli P et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994; 177:1547 52.
30. Lanier LL, Recktenwald DJ. Multicolor immunofluorescence and flow cytometry. In: Methods: a companion to methods in enzymology 1991; 2:192 9.
31. Schlegel RA, Stevens M, Lumley-Sapanski K et al. Altered lipid packing identilics apoptotic thymocytes. Immunol Letters 1993; 36:283 8.
32. Bakke AC, Kirkland PA, Kitridou RC et al. T lymphocyte subsets in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 745 50.
33. Horwitz DA, Stohl W, T lymphocyte, cytokine, and immune regulation in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus, 4th edn. London: Lea & Febiger, 1993:83 96.
34. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685 92.
35. Nieoletti I, Migliorati G, Paglieei MC et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1941; 139:271 9.
36. Amasaki Y, Kobayashi S, Takeda T et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechamism for lymphopenia. Clin Exp Immunol 1995; 99:245 50.
37. Mysler E, Bini P, Drappa J et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93:1029 34.
38. Boise LH, Ding L, Lindsten T et al. bcl-x, a bcl-2-related gene that functions as a dominant regular of apoptotic cell death. Cell 1993; 74:597 608.
39. + T cells from HIV-infected persons. J Immunol 1994; 153:412 20.
40. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28 T cells. AIDS 1994; 8:431 41.
41. + T lymphocytes during HIV-1 infection. J AIDS 1994; 7:245 53.
42. Klinman DM. B cell abnormalities characteristic of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus, 4th edn. London: Lea & Febiger, 1993:77 82.
43. Via CS, Handwerger BS. B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 1993; 5:570 4.
44. Sfikakis PP, Oglesby R, Sfikakis P et al. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus eythematosus (SLE). Clin J Immunol 1994; 96:8 14.
45. + cylotoxic and suppressor T cell clones. J Immunol 1990; 144:32 40.
46. Alvarado C, Alcocer-Varela J, Llorente L et al. Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus. J Autoimmun 1994; 7:763 73.
47. Sfikakis PP, Zografou A, Viglis V et al. CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:649 54.
48. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 1993; 74:609 19.
49. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621 7.
50. Watanabe-Fukunaga R, Brannan CI, Copeland NG et al. Lymphocyte proliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314 7.
51. Cohen PL, Eisenberg RA. The Ipr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 1992; 13:427 8.
52. Miyawaki T, Uehara T, Nibu R et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149:3753 8.
53. Owen-Schaub LB, Yonehara S, Crump III WL et al. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992; 140: 197 205.
54. Klas C, Debatin K-M, Jonker RR et al. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5:625 30.
55. Takahashi T, Tanaka M, Inazuwa J et al. Human Fas ligand: gene structure, ehromosomal location and species specificity. Int Immunol 1994; 6:1567 74.
56. Kayagaki N, Kawasaki A, Ebata T et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182:1777 82.
57. Boise LH, Minn AJ, Noel PJ et al. CD28 costimulation can promote T cell survival by enhancing the expression of bcl-xL. Immunity 1995; 3:87 98.
58. Boucher L-M, Wiegmann K, Fütterer A et al. CD28 signals through acidic sphingomyelinase. J Exp Med 1995; 181:2059-68.
59. Chan G, Ochi A. Sphingomyelin-ceramid turnover in CD28 costimulatory signaling. Eur J Immunol 1995; 25:1999 2004.
60. Haimovitz-Friedman A, Kan C-C, Ehleiter D et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180:525-35.
61. Gulbins E, Bissonnette R, Mahboubi A et al. Fas-induced apoptosis is mediated via a ceramid-initiated RAS signaling pathway. Immunity 1995; 2:341 51.
62. Gribben JG, Freeman GJ, Boussiotis VA et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995; 92:811 5.
63. Klummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182:459 65.
64. Walunus TL, Lenshow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1:405 13.
65. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270:985 8.
66. Tivol EA, Borriello F, Schweitzer N et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3:541-7.